NCT07820046
Nitazoxanide as Adjunct Therapy in Mild-to-Moderate Ulcerative Colitis
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Notable Recruitment opened
- Primary and study completion moved earlier from Jan 1, 2028 to Jun 1, 2027
- Start date changed from estimate of Jan 1, 2027 to Oct 25, 2026
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Change in Mayo Score (Mayo Scoring System for Ulcerative Colitis)
Timeframe: 12 weeks
Arms and interventions
Arm 1Placebo comparator
: Placebo + Standard Therapy Standard ulcerative colitis therapy Placebo tablets twice daily fo
Arm 2:Active comparator
Nitazoxanide + Standard Therapy Nitazoxanide 500 mg orally twice daily Standard ulcerative colitis therapy Duration: 12 weeks
Drugs: Nitazoxanide (NTZ)
Sites
2 sites in 1 country